KT
100 hedge funds and large institutions have $832M invested in KT in 2015 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 33 increasing their positions, 31 reducing their positions, and 17 closing their positions.
196% more call options, than puts
Call options by funds: $432K | Put options by funds: $146K
6% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 31
0.35% less ownership
Funds ownership: 25.51% → 25.16% (-0.35%)
5% less capital invested
Capital invested by funds: $872M → $832M (-$39.6M)
6% less funds holding
Funds holding: 106 → 100 (-6)
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| 1 |
KP
Kiltearn Partners
Edinburgh,
United Kingdom
|
+$5.77M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$4.69M |
| 3 |
Morgan Stanley
New York
|
+$4.16M |
| 4 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$1.79M |
| 5 |
GH
GAM Holding
Zurich,
Switzerland
|
+$1.47M |
Top Sellers
KT Hedge Fund Activity: Q2 2015 in Review
100 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in KT (KT) for Q2 2015, worth a combined $832M — down 4.5% from $872M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of KT and 12 opened new positions — a net loss of 5 holders — while 31 trimmed existing stakes and 33 added.
The largest buyer was Kiltearn Partners, adding an estimated $5.77M. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), exiting entirely with an estimated $14.1M sold.
- 100 institutional investors held KT (KT) as of Q2 2015, down from 106 in Q1 2015.
- Funds reported $832M of KT stock for Q2 2015, down 4.5% quarter-over-quarter.
- 12 funds opened new KT positions in Q2 2015 and 17 closed out, a net change of -5 holders.
- The largest KT buyer in Q2 2015 was Kiltearn Partners, an estimated $5.77M added.
- The largest KT seller in Q2 2015 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $14.1M sold.
Based on aggregated 13F filings for Q2 2015.